|
|
Volumn 6, Issue 6 SUPPL., 2011, Pages 90-96
|
|
European Medicines Agency, CAT Secretariat & US Food and Drug Administration
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ADVISORY COMMITTEE;
ARTICLE;
AUTHORITY;
BIOTECHNOLOGY;
CLASSIFICATION;
CLINICAL STUDY;
COMMITTEE FOR ADVANCED THERAPIES;
EUROPEAN MEDICINES AGENCY;
FOOD AND DRUG ADMINISTRATION;
GENE THERAPY;
HEALTH CARE ORGANIZATION;
MARKETING;
MEDICAL RESEARCH;
PRIORITY JOURNAL;
RISK ASSESSMENT;
RISK REDUCTION;
SAFETY;
STEM CELL TRANSPLANTATION;
TISSUE ENGINEERING;
ETHICS COMMITTEES, CLINICAL;
ETHICS COMMITTEES, RESEARCH;
EUROPE;
EVALUATION STUDIES AS TOPIC;
HEALTH SYSTEMS AGENCIES;
HUMANS;
PHARMACEUTICAL PREPARATIONS;
THERAPIES, INVESTIGATIONAL;
TISSUE ENGINEERING;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 80054099313
PISSN: 17460751
EISSN: 1746076X
Source Type: Journal
DOI: 10.2217/rme.11.86 Document Type: Article |
|
Times cited : (23)
|
|
References (1)
|
